NASDAQ:LENS - Presbia Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.95 +0.05 (+2.63 %)
(As of 08/21/2018 09:27 AM ET)
Previous Close$1.90
Today's Range$1.90 - $1.9952
52-Week Range$1.79 - $7.14
Volume3,292 shs
Average Volume9,996 shs
Market Capitalization$32.60 million
P/E RatioN/A
Dividend YieldN/A
Beta0.05
Presbia logoPresbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in South Korea, Australia, New Zealand, Italy, the Netherlands, Ireland, Canada, and Germany. The company was founded in 2014 and is headquartered in Dublin, Ireland.

Receive LENS News and Ratings via Email

Sign-up to receive the latest news and ratings for LENS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:LENS
CUSIPN/A
Phone353-551-1487

Debt

Debt-to-Equity RatioN/A
Current Ratio2.15
Quick Ratio2.11

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$10,000.00
Price / Sales3,346.20
Cash FlowN/A
Price / CashN/A
Book Value$0.18 per share
Price / Book10.83

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-16,990,000.00
Net MarginsN/A
Return on Equity-334.01%
Return on Assets-198.58%

Miscellaneous

Employees24
Outstanding Shares17,160,000
Market Cap$32.60 million

Presbia (NASDAQ:LENS) Frequently Asked Questions

What is Presbia's stock symbol?

Presbia trades on the NASDAQ under the ticker symbol "LENS."

How were Presbia's earnings last quarter?

Presbia PLC (NASDAQ:LENS) released its earnings results on Friday, August, 12th. The medical instruments supplier reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.25) by $0.07. The medical instruments supplier had revenue of $0.01 million for the quarter, compared to the consensus estimate of $0.04 million. View Presbia's Earnings History.

When is Presbia's next earnings date?

Presbia is scheduled to release their next quarterly earnings announcement on Friday, August, 24th 2018. View Earnings Estimates for Presbia.

What price target have analysts set for LENS?

2 brokerages have issued twelve-month target prices for Presbia's stock. Their forecasts range from $6.00 to $10.00. On average, they expect Presbia's stock price to reach $8.00 in the next year. This suggests a possible upside of 310.3% from the stock's current price. View Analyst Price Targets for Presbia.

What is the consensus analysts' recommendation for Presbia?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Presbia in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Presbia.

Who are some of Presbia's key competitors?

Who are Presbia's key executives?

Presbia's management team includes the folowing people:
  • Mr. Richard T. Fogarty, Chief Accounting Officer, VP of Fin. & Sec. (Age 67)
  • Mr. Vladimir Feingold, Consultant (Age 69)
  • Mr. Mark T. Yung, CEO & Chairman (Age 44)
  • Ms. Casey Jean Lind, Chief Operating Officer (Age 55)
  • Ms. Marie Cha, Director of Direct Response Marketing

When did Presbia IPO?

(LENS) raised $50 million in an initial public offering on Thursday, January 29th 2015. The company issued 4,200,000 shares at a price of $11.00-$13.00 per share. Jefferies served as the underwriter for the IPO.

Has Presbia been receiving favorable news coverage?

News coverage about LENS stock has trended somewhat positive this week, Accern Sentiment reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Presbia earned a news impact score of 0.16 on Accern's scale. They also gave headlines about the medical instruments supplier an impact score of 47.19 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View Recent Headlines for Presbia.

How do I buy shares of Presbia?

Shares of LENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Presbia's stock price today?

One share of LENS stock can currently be purchased for approximately $1.95.

How big of a company is Presbia?

Presbia has a market capitalization of $32.60 million and generates $10,000.00 in revenue each year. Presbia employs 24 workers across the globe.

How can I contact Presbia?

Presbia's mailing address is SANDYFORD OFFICE CENTRE SUITE 7 17 CORRIG ROAD, DUBLIN 18 L2, . The medical instruments supplier can be reached via phone at 353-551-1487.


MarketBeat Community Rating for Presbia (NASDAQ LENS)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  108 (Vote Outperform)
Underperform Votes:  118 (Vote Underperform)
Total Votes:  226
MarketBeat's community ratings are surveys of what our community members think about Presbia and other stocks. Vote "Outperform" if you believe LENS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LENS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/21/2018 by MarketBeat.com Staff

Featured Article: Growth Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel